In the acute COVID-19 cases, SARS-CoV-2-specific CD8+ T cells were characterized by activation marker (CD38, HLA-DR, and Ki-67) and predominantly expressed IFN-γ, granzyme B, perforin, and CD107a, with cytotoxic effector functions 45, 53. The gene discussed is PRF1; the disease is COVID-19.